Evidence map›Paper›PMID 41737134›Full record

SynthesisFrontiers in microbiology2025

Visualized analysis of core themes and emerging frontiers in global chikungunya virus studies.

Jing Tian, Yonggang Li, Yuanlong Zhao, Xiaoli Tao

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jing TianDepartment of Immunity and Pathogenic Microbiology, Jinzhou Medical University, Jinzhou, China.
Yonggang LiSchool of Basic Medical Sciences, Shenyang Medical College, Shenyang, China.
Yuanlong ZhaoDepartment of Immunity and Pathogenic Microbiology, Jinzhou Medical University, Jinzhou, China.
Xiaoli TaoDepartment of Immunity and Pathogenic Microbiology, Jinzhou Medical University, Jinzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Chikungunya virus (CHIKV) is a mosquito-borne alphavirus that has caused multiple outbreaks worldwide in recent years, resulting in millions of infections and severe complications such as chronic arthritis, posing an ongoing threat to global public health. Objective: This study employs bibliometric methods to systematically analyze the core themes, development trends, and research frontiers in CHIKV research, aiming to provide a scientific basis for research planning and prevention strategies. Methods: Based on the Web of Science Core Collection database, a total of 3,709 relevant publications from 2015 to 2024 were included. Visualization tools such as VOSviewer and CiteSpace were used to analyze countries/regions, institutions, authors, journals, keywords, and co-citation networks. Results: The results indicated that the United States, Brazil, and India were the most productive countries, while French institutions stood out in research output. Scott C. Weaver was identified as the most prolific author. Journals including PLOS Neglected Tropical Diseases, Viruses, and the Journal of Virology demonstrated significant influence in this field. Co-citation and keyword cluster analyses revealed that phylogenetic analysis, epidemiology, pathogenesis, drug therapy, and vaccine development represent current research hotspots. International collaboration plays a key role in promoting global phylogenetic studies and data integration. Conclusions: CHIKV research is expanding from epidemiology to pathogenic mechanisms, targeted therapies, and public health prevention strategies. Future efforts should focus on viral evolution mechanisms, host immune interactions, multi platform vaccine development, and the construction of global risk prediction models to address the persistent challenges posed by CHIKV outbreaks.

Indexed as

bibliometricschikungunya virusCiteSpacetrendsVOSviewer

Identifiers

PMID41737134
PMCPMC12927478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.